Stock listing
Kyverna Therapeutics, Inc.
Selected listing: KYTX · NASDAQ · USD · US
Kyverna Therapeutics, Inc. (NASDAQ:KYTX), Health Technology. Latest release Oct 7, 2026: Kyverna Therapeutics to Present Positive Data in Stiff Person…
- Ticker
- NASDAQ:KYTX
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
About Kyverna Therapeutics, Inc.
Kyverna Therapeutics, Inc. (ticker: KYTX) is a public company based in the United States, focused on developing innovative therapies. The company aims to advance its research and development efforts to address unmet medical needs.
Latest news from Kyverna Therapeutics, Inc.
Kyverna Therapeutics to Present Positive Data in Stiff Person Syndrome and Progressive Multiple Sclerosis at MSToronto2026
October 6, 2026
Kyverna Therapeutics Reports Positive One-Year Data Demonstrating Durable Clinical Responses and Favorable Safety Profile for Miv-cel in Stiff Person Syndrome and Generalized Myasthenia Gravis
September 24, 2026
Kyverna Therapeutics to Present at Upcoming Investor Conferences
September 2, 2026
Kyverna Therapeutics Reports Pipeline Progress and Second Quarter 2026 Financial Results
August 11, 2026
Kyverna Therapeutics and ElevateBio Enter into Commercial Manufacturing and Supply Agreement for Miv-cel
July 27, 2026
Research Kyverna Therapeutics, Inc.
Kyverna Therapeutics, Inc. company profile
View the public company page for Kyverna Therapeutics, Inc. on 6ix.
Kyverna Therapeutics, Inc. news
Read company news and market updates connected to Kyverna Therapeutics, Inc..
Kyverna Therapeutics, Inc. investor events
Find investor webinars, events, and replay context for Kyverna Therapeutics, Inc..